15 employees
CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases
2017
$55M
from 6 investors over 6 rounds
CuraSen Therapeutics, Inc. raised $55M on October 17, 2018
Investors: Chiesi Ventures, Pappas Capital, Alta Partners, Tekla Capital Management, Longitude Capital and New Leaf Venture Partners